iZafe Group

iZafe Group EPS

The Earnings per Share (EPS) of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is -0.05 SEK. In the previous year, Earnings per Share (EPS) was -0.07 SEK — a change of -38.74% (higher).

EPS

-0.05SEK

YoY

-38.74%

Last updated:

Earnings per Share (EPS) of iZafe Group is 2025 -0.05 SEK. Earnings per Share (EPS) of iZafe Group was 2024 -0.07 SEK. It decreases by -38.74% higher compared to the previous year.

The iZafe Group EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-1.05 SEK
Jan 1, 2020
-0.36 SEK
Jan 1, 2021
-0.34 SEK
Jan 1, 2022
-0.22 SEK
Jan 1, 2023
-0.13 SEK
Jan 1, 2024
-0.07 SEK
Jan 1, 2025
-0.05 SEK
Jan 1, 2026 (e)
0.00 SEK
The iZafe Group EPS history
YEAREPSYoY
est0.00SEK-100.00%
-0.05SEK-38.74%
-0.07SEK-42.04%
-0.13SEK-41.66%
-0.22SEK-34.71%
-0.34SEK-6.48%
-0.36SEK-65.54%
-1.05SEK+32.51%
-0.79SEK+87.89%
-0.42SEK-37.16%
-0.67SEK+128.67%
-0.29SEK-26.22%
-0.40SEK-56.14%
-0.90SEK+147.74%
-0.36SEK+3,005.81%
-0.01SEK-16.35%
-0.01SEK-98.10%
-0.74SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

Earnings per Share (EPS) of iZafe Group is -0.05 SEK in 2025.

Earnings per Share (EPS) of iZafe Group changed from -0.07 SEK to -0.05 SEK, representing a -38.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) iZafe Group since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — iZafe Group

All Key Metrics — iZafe Group